Although the severity of the shortage of chemotherapy agents, particularly with the platinum-based therapies cisplatin and carboplatin, has receded from the heights seen earlier in 2023, clinicians are still dealing with its ramifications and having to strategically manage how they employ certain chemotherapies.
Alan Tan, MD, discusses how utilizing circulating tumor DNA may provide valuable insight into when to escalate vs de-escalate treatment for patients with renal cell carcinoma.
SINGAPORE - The authorities in India, including Customs officials, are on the lookout for travellers acting as “gold mules”, who return home with jewellery they had agreed to carry for a fee. This comes in the wake of a spike in gold smuggling to the country, and amid reports of syndicates targeting travellers at various airports in jurisdictions in the.
From the Museum of Modern Art to the history-focused Tenement Museum to the idyllic Queens County Farm Museum, these are the 10 best museums in New York City.
Circulating tumor DNA which is observed via blood test may be helpful in determining which patients with kidney cancer need more intense treatment and who can have their therapies deescalated.